Animal NDC 17153-340-16 Furazone

Animal Product Information

Field Name Field Value
Animal NDC Code 17153-340-16
Proprietary Name Furazone What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Furazone What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Squire Laboratories
Product Type Otc Animal Drug
Active Ingredient(s)
  • Nitrofurazone
Inactive Ingredient(s)
  • POLYETHYLENE GLYCOL 400 (B697894SGQ)
  • POLYETHYLENE GLYCOL 3350 (G2M7P15E5P)
  • POLYETHYLENE GLYCOL 400 (B697894SGQ)
  • POLYETHYLENE GLYCOL 3350 (G2M7P15E5P)
Marketing Category NADA - NEW ANIMAL DRUG APPLICATION What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number NADA132427 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Furazone Images

Furazone Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Furazone



INDICATIONS: For the prevention or treatment of surface bacterial
infections of wounds, burns, and cutaneous ulcers.

ADMINISTRATION: Apply directly on the lesion with a spatula or first
place on a piece of gauze. Application of a bandage is optional. This
preparation should be in contact with the lesion for at least 24 hours.
The dressing may be changed several times daily or left on the lesion for
a longer period.

CAUTION: In case of deep or puncture wounds or serious burns, use
only as recommended by a veterinarian. If redness, irritation or swelling
persists or increases, discontinue use; reconsult veterinarian. Avoid
exposure to alkaline material and fluorescent lighting.

Furazone Label


Furazone Warnings



“HUMAN WARNING”
CARCINOGENESIS: NITROFURAZONE, THE ACTIVE INGREDIENT OF
FURA-ZONE OINTMENT HAS BEEN SHOWN TO PRODUCE MAMMARY
TUMORS IN RATS AND OVARIAN TUMORS IN MICE. SOME PEOPLE
MAY BE HYPERSENSITIVE TO THIS PRODUCT. EITHER WEAR GLOVES
WHEN APPLYING, OR WASH HANDS AFTERWARDS.

STORE AT CONTROLLED ROOM TEMPERATURE, 20-25⁰C (68-77⁰F)
KEEP AWAY FROM EXCESSIVE HEAT OR DIRECT SUNLIGHT

DO NOT USE ON HORSES INTENDED FOR HUMAN CONSUMPTION


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.